Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-12-02

Clinical Trial Update: A Post Marketing Surveillance Study on the Safety and Effectiveness of Prucalopride in the Treatment of Chronic Constipation

View source ↗

Summary

This entry indicates that a post-marketing surveillance study evaluating the safety and effectiveness of prucalopride for chronic constipation has been withdraw…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRUCALOPRIDE (Prucalopride)

Snippet

Sponsor: Janssen Pharmaceutica | Conditions: Chronic Constipation | Status: WITHDRAWN